Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

1.46
Delayed Data
As of 4:00pm ET
 -0.02 / -1.35%
Today’s Change
1.40
Today|||52-Week Range
4.69
-41.60%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close1.48
Today’s open1.48
Day’s range1.45 - 1.50
Volume32,479
Average volume (3 months)155,799
Market cap$29.7M
Dividend yield--
Data as of 4:00pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+9.64%
Earnings growth (this year)+42.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+105.25%
P/E ratioNM
Price/Sales1.60
Price/Book4.29

Competitors

 Today’s
change
Today’s
% change
AMPEAmpio Pharmaceutical...+0.16+15.67%
CTRVContraVir Pharmaceut...-0.02-2.44%
PPHMPPeregrine Pharmaceut...+0.14+0.58%
PRPHProPhase Labs Inc+0.01+0.48%
Data as of 8:00pm ET, 10/18/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$19.9M
Annual profit (last year)-$19.1M
Net profit margin-95.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
CFO, Secretary &
Principal Accounting Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts